A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...

If you're struggling with chronic low back pain, then this is for you. Brad: So we're going to show you three different ...

Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...